Bone response to degradable thermoplastic composite in rabbits

Area of Science:

• Biomaterials Science
• Orthopedic Research
• Tissue Engineering

Background:

• Bioactive glass (BAG) composites are promising for bone regeneration.
• Poly(epsilon-caprolactone-co-DL-lactide) is a biodegradable polymer used in medical devices.
• Evaluating the in vivo performance of BAG-copolymer composites is crucial for clinical translation.

Purpose of the Study:

• To assess the biologic behavior of a bioactive glass (S53P4) and poly(epsilon-caprolactone-co-DL-lactide) copolymer composite.
• To investigate bone healing and material integration in experimental bone defects in rabbits.

Main Methods:

• New Zealand white rabbits with surgically created bone defects in the femur and tibia were used.
• Defects were filled with composites containing varying concentrations and granule sizes of BAG (S53P4) and copolymer.
• Histological analysis was performed at 8 and 16 weeks post-implantation.

Main Results:

• The composite material demonstrated biocompatibility, with minimal fibrous encapsulation at 16 weeks.
• Bone ingrowth was observed, particularly in contact with larger BAG granules.
• No signs of polymer degradation were detected throughout the 16-week study period.

Conclusions:

• The composite of BAG (S53P4) and poly(epsilon-caprolactone-co-DL-lactide) is biocompatible with bone tissue.
• The material supports bone regeneration and shows good integration within the observed timeframe.
• Further research may explore optimizing BAG concentration and granule size for enhanced bone healing.